Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.

Increased respiratory syncytial virus activity in parts of the southeastern United States: new prevention tools used to protect patients. Updated September 5, 2023. Accessed January 17, 2024.

In comparison to previous periods, a larger fraction of the pediatric population hospitalized due to respiratory syncytial virus infections between 2022 and 2023 was two to five years of age (34% ...

Researchers reported the immunogenicity, efficacy, and safety of the MVA-BN (modified vaccinia Ankara-Bavarian Nordic)-RSV (respiratory syncytial virus) vaccine against RSV-A (RSV subtype A ...

TUESDAY, Jan. 7, 2025 (HealthDay News) -- For immunocompromised individuals, antibody response to respiratory syncytial virus (RSV) vaccines is heterogeneous and about 40 percent do not ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical ...

Cases of respiratory syncytial virus, known as RSV, have surged, the flu season has come early, and covid-19 cases are rising. Here’s what you need to know.

As the United States heads into the colder weather months, cases of respiratory syncytial virus have been ticking up across the country.. For the week ending Nov. 25, there were 8,863 positive RSV ...

Respiratory syncytial virus, more commonly known as RSV, sends thousands of children to the hospital every year in the US. But during September and October 2022, health professionals across the ...

COVID-19, the flu and respiratory syncytial virus (RSV) are together driving a wave of respiratory illnesses. But all three have very similar symptoms that overlap. We help you zero in on which ...